August 22, 2008 - The 23rd Annual Advances in Contrast Ultrasound: Atherosclerosis Imaging and Interventions/Bubble ...
Contrast Media
Contrast media, also called contrast agents, are used to enhance the blood and perfusion in tissues. This includes iodine based contrast for on computed tomography (CT), gadolinium based agents for MRI and lipid bubble contrast agents used in ultrasound.
Bracco's Isovue (iopamidol injection) X-ray/CT contrast is reportedly a safe and effective nonionic contrast agent ...
August 18, 2008 – Maximus, a business unit of infusion therapy firm Medegen Inc., today announced as a result of a co ...
Bracco Diagnostics and Guerbet recently announced they had formed a strategic, global collaboration for the research ...
August 14, 2008 - Arlington Medical Resources (AMR), a provider of market intelligence for the pharmaceutical and ...
August 7, 2008 – MEDRAD Inc. completed today the first installation of its Intego PET Infusion System at the University ...
August 4, 2008 - There is no statistically significant difference between iopamidol-370 (Isovue-370) and iodixanol-320 ...
A patient’s chance of recovery can be directly impacted when a diagnosis is missed or delayed. To get the right ...
July 31, 2008 - Bristol-Myers Squibb Co. today offered $4.5 billion in cash for its cancer drug partner, ImClone Systems ...
July 29, 2008 – GE Healthcare reported results from a Phase I clinical trial of GE-067, a [18F]-labeled PET diagnostic ...
July 24, 2008 – Covidien recently launched the Optistar Elite contrast delivery system, designed to inject contrast ...
Product Indications and Use: CLARISCAN (gadoterate meglumine) is a gadolinium-based contrast agent indicated for ...
July 17, 2008 - GE Healthcare’s iodixanol, an isosmolar contrast medium, shows lower incidence of elevated serum ...
July 10, 2008 - A novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), has ...
The FDA approved Bayer HealthCare Pharmaceuticals’s EOVIST (Gadoxetate Disodium) Injection, a gadolinium-based contrast ...
With the use of contrast agents and radiotracers on the rise, GE Healthcare has seen increases in demand across their ...
July 8, 2008 – The FDA approved Bayer HealthCare Pharmaceuticals’s EOVIST (Gadoxetate Disodium) Injection, a gadolinium ...
June 22, 2008 - Customized microscopic magnets that could possibly be injected into the body could add color to magnetic ...
June 18, 2008 – MEDRAD gained FDA 510(k) clearance for a new Fluorodeoxyglucose (FDG) infusion system for positron ...
June 18, 2008 – Bracco Diagnostics showcased its Cardiac PET Perfusion Imaging with CardioGen-82, a Rubidium Rb 82 ...
June 17, 2008 – Findings indicate that when used with PET technology, BMS747158 demonstrates a favorable radiation ...
June 13, 2008 - MEDRAD signed a distribution and co-marketing partnership agreement with PETNET Solutions, a fully owned ...
June 12, 2008 – The FDA designated for priority review, the New Drug Application (NDA) for GE’s AdreView, a molecular ...
June 12, 2008 - There is a lack of universally applied standards for administering radiopharmaceutical doses to children ...